Psychology - Spark Newswire

2 minute read

Year Of Volatility: Stocks Exposed To Russia-Ukraine War See Big Gains/Losses

Today, 9:53 PM

It's been one year since the world watched as Russian President Vladimir Putin mobilized over 100,000 troops along Ukraine's border, signaling a possible full-scale attack.

ALB

2 minute read

Layoffs ‘Kill People’ And Big Tech Firms Are ‘Copycats’ In Making Decision, Business Professor Says

By AJ Fabino

Today, 9:53 PM

As the tech industry continues to shed jobs by the thousands, a business professor is sounding the alarm on the dangerous consequences of following the herd.

AMZN

4 minute read

What The Careful CEO Should And Shouldn’t Talk About: A Handy Guide

By Mark Fritz

Today, 9:53 PM

CEOs walk a fine line when it comes to talking about hot-button issues like transgender rights or gun control or arming transgender people to fight for the right of immigrants to have affordable health care and equal pay without enduring global warming.

GOOG

3 minute read

5 Ways The Super Rich Spend $50 Billion

By Stephen Mugo Weru

Today, 9:53 PM

What would you do if you had $50 billion? You'd probably buy everything you've ever wanted, but you still wouldn’t be able to spend all the money on yourself. Figuring out how to spend all that money would be your biggest problem. I mean, how many cars can you have? How many houses can you own? It’s pretty finite, right?

AMZN

2 minute read

Major Depressive Disorder Could Soon Have Treatment Option Via Cybin’s Psilocybin Analog

By Lara Goldstein

Today, 9:53 PM

Cybin Inc. (CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics," has submitted an Investigational New Drug (or “IND”) application to the FDA.

CYBN

2 minute read

High Hopes For Alcohol Use Disorder Treatment: Clearmind’s Successful Pre-IND Meeting With The FDA

By Lara Goldstein

Today, 9:53 PM

The meeting, which took place on May 18 between the psychedelic pharmaceutical biotech company Clearmind Medicine Inc. (CMNDF) and the US Food and Drug Administration marks the completion the pre-IND New Drug Application stage.

CMNDF

3 minute read

Why Traders Make Markets Inefficient

By Wayne Duggan

Today, 9:53 PM

The Efficient-Market Hypothesis (EMH) is a popular theory within the world of finance. The idea behind EMH is that the stock market is "informationally efficient," meaning that a stock is always accurately valued at any given time based on the information that is publicly available about that stock.

2 minute read

Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress

By Fermin Orgambide

Today, 9:53 PM

After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.

DELCF

1 minute read

Beckley Retreats Launches To Offer Magic Mushroom Retreats In Jamaica

By Fermin Orgambide

Today, 9:53 PM

Following Silo Wellness’ (OTCQB: SILFF) steps, the newly launched Beckley Retreats

SILFF

2 minute read

Field Trip Launches At-Home Ketamine Treatment In Partnership With Nue Life

By Natan Ponieman

Today, 9:53 PM

Field Trip Health (NASDAQ: FTRP), a company offering mental health treatment using ketamine therapy, has inked a unique deal with Nue Life Health to expand its service offerings to at-home treatment.

FTRP